China NT Pharma Group Company Limited 357,032, ,479,000 86,553,000 35,703, ,328, ,775,500 86,553, % 0.003% 0.005%
|
|
|
- 悠 吉
- 9 years ago
- Views:
Transcription
1 China NT Pharma Group Company Limited 中國泰凌醫藥集團有限公司 ( 於開曼群島註冊成立之有限公司 ) 股份代號 : 1011 全球發售 獨家全球協調人及獨家保薦人 聯席賬簿管理人及聯席牽頭經辦人
2 China NT Pharma Group Company Limited 357,032, ,479,000 86,553,000 35,703, ,328, ,775,500 86,553, % 0.003% 0.005% C (i) 144A (ii) S
3 (1) (3) (6)
4 (1)... (1) (2) 8 8. (3) 3. (4) (5) (6) (7) (8)
5 i iii
6 I-1... II-1... III-1... IV-1 TPG... V-1 TPG... VI-1... VII-1... VIII-1... IX-1
7 %23.4%6.9% 10.7% 1 8.7% 1 II 64% 54% II 79% 72% 3 1 Frost & Sullivan II II II II 2 Frost & Sullivan 3 Frost & Sullivan
8 2 26,5003, % 4 1,250 20% HIB 73% II27% 4
9 (37.1%) II A+C 57.1% 34.9%28.0% 47.6% MENET 5 5 MENET
10 42.9% 65.1% 53.8% 86.3% IMS70 15 I II II II 64% I 20.7% II 24.4% 31.3%39.3% , % II 15.2% 74 6 Frost & SullivanII II
11 Frost & SullivanII 7.6% 1,414.02, , % % % % 2.4%
12 643.5 a % b. 41 c. d. e. 15.9% 1, %
13 A+C Meningococcal ACYW 19.7% 13.9% 18.5%
14 34.2% 61.4% 38.2% 64.7%42.9% 66.5%II I 3.0% 5.1% 1.8%0.6% 0.9% 0.4% % 28% 15.8%50.3% 1.6%5.2% 29% 28%
15 58.2% 43.2% 47.5% TPG TPG NT Holdings TPGANT Holdings TPG TPG20.32% NT Holdings Golden Base TPG 250 TPG
16 Golden Base Golden BaseTPG
17 (i) (ii) (iii) (iv)
18 I
19
20 II II
21 ... 1,413,985 2,395,038 2,667, (1,178,904) (1,915,167) (2,004,775) (1) , , , ,196 7,670 28, (44,311) (1,739) 8, (108,129) (237,418) (354,456)... (43,147) (55,999) (90,056) (1)... 87, , , (14,277) (17,128) (45,379)... 73, , , (20,150) (58,087) (80,748)... 53, , , , , , (2)(3)... 53, , ,410 (1) 7.9 (2) 12.3 (3)
22 , , , , , , ,514 1,213,754 1,738, ,262 55,990 47, , , , ,269 1,713,000 2,467, ,066 1,947,188 2,755, ,005 2, ,005 2, ,188 1,042,657 1,358, , , , ,000 6, ,823 54,931 51, ,508 1,608,307 2,250, ,390 1,610,312 2,253, , , , , , , ,130 15,130 15, , , ,277
23 1, % % % 10%
24 20% % %
25
26 ,081,916, = (1)... 4,912 6,491 (2) (3) (1) 1,081,916,500 (2) ,081,916,500 (3) 1,081,916,
27 NT Holdings Business Monitor International
28 Golden Base Frost & Sullivan Frost & Sullivan Golden Base Golden Base Investment Limited
29 35,703,500 Golden Base IMS IMS Health Incorporated 321,328, ,775,500 86,553,000
30 MENET 270,479,000 NT BVI NT Pharma (Group) Co., Ltd NT Holdings NT Pharma (Holdings) Company Limited
31 53,554,000 15% Wyeth Inc. 144A S S 144A 144A
32 86,553,000 12,982,500 TPG Biotech TPG Star A NT Holdings SmithKline Beecham Glaxo Wellcome 80% TPG TPG Biotech TPG Star TPG Biotech TPG Biotech III Jaguar Ltd.
33 TPG Star TPG Star Jaguar Ltd.
34
35 GMP
36 GSP ISO9001 PEG A+C A+C
37 Meningococcal ACYW PEG
38 - - I II AB
39
40
41 , , % 57.0% 56.9% % % 20.4%9.5% 13.5% % % 2.4% %
42 A+C Meningococcal ACYW 19.7% 13.9% 18.5% SmithKline Beecham
43 63.4% 65.6% 60.7% 44.1% 46.6% 46.5% 85.0% 86.5% 82.3%
44 20.1% 4.8%
45 II I 3.0% 5.1% 1.8% 0.6% 0.9% 0.4% % 28%15.8% 50.3%1.6% 5.2%
46 19.0% 26.2% 30.5%
47 28.1
48 (2-8 C) %
49
50 1 1 Frost & Sullivan II II II II
51 1, ,395.02, %
52
53 24% 25% , % 27.6%
54 137.9
55
56 74 II
57 I IIII II III II I
58
59
60 0.5% 20% 1% 1%
61 (H1N1) (H1N1) (H1N1)
62 25% (i) (ii) (iii) (iv) 25% 10% 10%
63 10% 50%
64 46.68%
65
66 1. 14A (1)(b)1A 27 I 10(d) 17.02(1)(b) 1A 27 I342(1)(b) 10 (i) (ii)
67 17.02(1)(b)1A 27 (i) D. 10(d) 17.02(1)(b)1A 27 (ii) (i) (1) (2) (3)(4) (iii) (iv) D. (v) 17.02(1)(b)1A 27 I10 (vi) 342AI10(d) (i) D. 10(d)
68 (ii) (i) (1) (2) (3)(4) (iii) I10
69
70 (i) (ii) 44B(1) Codan Trust Company (Cayman) Limited
71
72 A E A PMB West University Avenue E1 Paso Texas US C A A 3 A1
73
74 Conyers Dill & Pearman Cricket Square Hutchins Drive P.O. Box 2681 Grand Cayman KY Cayman Islands
75 XI Cricket Square Hutchins Drive PO Box 2681 Grand Cayman KY Cayman Islands CPA FCCA A E
76 Codan Trust Company (Cayman) Limited Cricket Square, Hutchins Drive P.O. Box 2681 Grand Cayman, KY Cayman Islands
77 Frost & Sullivan Frost & Sullivan Frost & Sullivan Frost & Sullivan Frost & Sullivan Frost & Sullivan Frost & Sullivan Frost & Sullivan 11,75919, % GDP16.5% GDP
78 16,456 29, % GDP % % Euromonitor International
79 Euromonitor International 1,94713,240Euromonitor International 22,972156,210 5,026 11, % Euromonitor International 123Euromonitor International %
80 %... 2, , , % , , % , , % , , % , , % , , % % , , % , , % Euromonitor International Euromonitor International GDP 8% 11% Euromonitor International GDP4.1% (16.3%) (10.9%) GDP GDP Euromonitor International
81 ( ) 90% 65
82 % I II III
83
84 Frost & Sullivan Frost & Sullivan Frost & Sullivan Frost & Sullivan % ,600
85 Frost & Sullivan 2% 3%27% Frost & SullivanII % H1N1 I IIIIII I II I III I II 33%
86 III I II % 24.4% Frost & Sullivan II
87 Frost & Sullivan 3,534 28,407 II Frost & Sullivan 41 II II33%Frost & SullivanII Frost & Sullivan % (%) Frost & Sullivan
88 II II Frost & Sullivan II 74 Frost & Sullivan II 7.6% Frost & Sullivan Frost & SullivanZuellig Pharma Asia Pacific Frost & Sullivan 18.0%23.4%6.9%
89 10.7% 1 Frost & Sullivan Frost & Sullivan 1 II II
90 Frost & Sullivan % Frost & Sullivan % (%) (%) Frost & Sullivan Frost & Sullivan Frost & Sullivan 4% Frost & Sullivan
91 Frost & Sullivan 0.4% 8.7% Frost & Sullivan 2 4.7% Frost & Sullivan II % Frost & Sullivan 37.1% Frost & Sullivan % Frost & Sullivan A C 21% 27.9Frost & Sullivan 68.1% 91.9 Frost & Sullivan 2,000 Frost & Sullivan % 300 Frost & Sullivan % 2 II II
92 Business Monitor International 4683, % 15.3% Business Monitor International Business Monitor International 2, % Business Monitor International 1, % %
93 Business Monitor International 2, % % Business Monitor International 26.9%15.6% MENET 23.5% 17.4% 13.4% MENET IMS %
94 IMS 20 Frost & Sullivan
95 IMS Frost & Sullivan Frost & Sullivan Frost & Sullivan52,000 Frost & Sullivan Frost & Sullivan351,800 Frost & Sullivan Frost & SullivanFrost & Sullivan Frost & Sullivan Frost & Sullivan Frost & Sullivan
96 (a) (b) (c)
97 (d) (e) (f) (g) (h) (i)
98 GSP GSP GSP III I II II I II II II II II
99
100
101
102
103
104 80%
105
106
107 25%
108 10% 15% 18% 20% 22% 24% 25%24% 25% 17.0% *3%
109 3.0% 20.0%
110 SmithKline Beecham 80% 48 20,500 TPGTPG Biotech TPG StarNT Holdings NT Holdings 9.11% 18.21%ATPG 11 ISO9001
111 Smithkline Beecham Smithkline Beecham , ,000
112 TPG NT Holdings TPG NT Holdings TPG A+C TPG
113 TPG TPGNT Holdings NT Holdings TPG NT Holdings Golden Base TPG TPG Biotech TPG Star A NT Holdings 9.11% 18.21% TPG Biotech TPG Star 8,333,333 16,666,667A TPG Biotech TPG Star5 10 TPG3,333,333 6,666,667 TPG NT HoldingsNT Holdings TPG TPGANT Holdings A NT HoldingsNT Holdings NT Holdings TPG A A TPGA TPG Biotech TPG Star A A TPG Biotech TPG StarNT Holdings1,3632,726 A NT Holdings 12% 24%
114 TPG NT Holdings ANT Holdings TPG TPGNT Holdings NT HoldingsNT Holdings , A 125, AGolden Base908,500,000 TPG Biotech170,375,000 A TPG Star340,750,000 A NT Holdings TPG Biotech TPG Star TPG NT Holdings101,625,000 ATPG NT Holdings10 101,625,000 A NT Holdings ,625,000 NT Holdings Golden Base101,625,000
115 NT Holdings NT Holdings Golden Base... 1,010,125, % TPG Biotech ,249, % A TPG Star ,500, % A Golden Base TPG Biotech TPG Star Golden Base TPG A TPG TPGA TPG TPG NT HoldingsTPG TPG TPG TPGNT Holdings TPG Biotechnology Partners III L.P. TPG BiotechTPG Star L.P. TPG Star ANT Holdings ANT Holdings ANT Holdings TPGA
116 TPG NT HoldingsA TPG TPG NT Holdings TPG 30NT Holdings TPG Star TPG Biotech NT HoldingsTPG Star TPG Biotech ANT Holdings TPG NT Holdings TPG NT Holdings TPG TPG 37.8% 30 TPG TPG Golden Base ,062, % TPG Biotech... 73,273, % TPG Star ,549, % ,032, %
117 TPG TPG TPG TPG TPG NT Holdings TPG TPG TPG TPG TPGA Golden Base Golden Base NT Holdings 250 TPGANT Holdings 250Golden Base Golden Base TPGTPG Golden Base TPG TPG 15% TPG 20.32% TPG Golden Base TPG 35.32%TPG Golden Base TPG Golden Base TPG
118 TPG Golden Base TPG TPG TPG Star TPG BiotechTPGTPG 480 TPG TPG NT Holdings NT Holdings NT Holdings90,614,362 90,614, % NT Holdings 64 89,914,35789,914,357 NT Holdings 45,307,181 45,307, % 70% NT Holdings
119 % 3. Tai Ling Pharma Company Limited NT Holdings 626,250,000, NT Holdings (a) Tai Ning Pharmaceutical (Investment) Company Limited Goldwise Resources Limited NTP (China) Investment Co., Limited NT Pharma (HK) Limited NT BVI NT Holdings 451.3NT BVI NT Holdings 21.4 NT BVI
120 NT Holdings NT BVI NT Holdings9 1 (b) (c) NT Holdings NT BVINT Holdings 811,437, ,437,500NT Holdings NT Holdings Golden Base TPG Biotech TPG StarGolden Base TPG Biotech TPG Star NT Holdings Golden Base ,062, % TPG Biotech ,124, % TPG Star ,250, %
121 %
122 %23.4%6.9% 10.7% 1 8.7% 1 II 64% 54% II 79% 72% ,5003, % 4 1,250 20% 4 1 Frost & Sullivan II II II II 2 Frost & Sullivan 3 Frost & Sullivan 4
123 HIB 73% II27% (37.1%) II A+C 57.1% 34.9% 28.0% 47.6%
124 MENET % 65.1% 53.8% 86.3% IMS MENET
125 I II II II64% I 20.7% II 24.4% 31.3%39.3% , % II 15.2% 6 Frost & Sullivan
126 74 Frost & SullivanII 7.6% 1,414.02, ,668.0 %... 1,413,985 2,395,038 2,667, ,334 1,230,340 1,167, , , , , , , , , , , , , ,626 47,100 44, ,771 60,216 64, , , , ,862 13,119 10,255 (10.7) 1
127 II 12.9% 8,500 I 6 14 III I 20.7% II 24.4% II 64% II IMS 20 10
128 IMS70 15 Frost & Sullivan 0.4% 8.7% 7 Frost & Sullivan II 18.0% 23.4% % II15.2% 4.0% 10.7% 16.6% 24.9% % 7 Frost & Sullivan II II 8 Frost & Sullivan II II
129 % 2,80020,500 90% 3804, (Jiangsu Pharmaceutical Quality Control Society) % II37.1% 9 Frost & Sullivan
130 II54% II 22%480 A+C 90 II ACYW4 II 34.9% 850
131 26,5003, %1, % % 29.0% 19.7% (1) (1) (1) % 35.7% 31.4% (1) (1) (1) % 24.3% 12.9% (1) (1) (2) % 12.4% 8.1% (2) (3) (4) MENET 10 11
132 % 15 75% 60%
133 21,000 73% 4,20038,000
134 85% 20510
135 20
136 12 II 54% % % % , ,230, ,167, , , , , ,479, ,524, % 43.8% Frost & Sullivan 23.4% % 10.7% II64% % II 12 Frost & Sullivan II II II II 13 IIII
137 27% 48
138 % 40.0% 37.9% % 23.4% 27.5% % 22.6% 20.2% % 9.7% 9.5% % 4.3% 4.9% % 100% 100% 50
139 A+C AC
140 (i) (ii) (iii) (iv)
141 I II 15 II B 6 II B 6 II 3 5 II II 1 19 II 8 II I 24 3 II 6 3 II 3 II AC 3 5 II MF59-65 II 6 II I
142 I II II PCECV II I III 50.2% 37.9% 31.2%
143 100 20%
144 19 (Jiangsu Quality Control Society) 48 24
145 7,778 12,972 28,500
146 2, %II 87% 1 5% % % 2.4% 14
147 542109
148 , ,053, ,107, , , , , , , , , ,
149 8.7% 16 20,500 II (1) 131 (2) 16 Frost & Sullivan II II
150 % % %... 89, , ,
151 , %
152
153
154 II 0 15 II 16 A+C A+C ACYW ACYW 2 200
155 20, ,000 10,000 2, ,000 18,000 20,500 % % % , , , , , ,
156 396 26,5003, %1, %
157 % 24.2% 28.5% 36.6% 63.2% 66.6% MENET 34.2%19.7% 74% 41% 1,788
158 MENET 46.6% 31.4% 48% 1,140,000 1,656, % 309 MEMET 18.0% 8.1% 407, , % ,000 1,487, % MEMET 35.0% 12.9% 153
159 1,419,000 6,930, % 1, % 0.1% PEG
160 AIDS-KSPEG
161 90
162
163
164 GMP
165 (1) % % (1)
166 Yiling Yiliang
167 13.3% 6.6% 7.4% 4.5% 2.5% 3.2% 80% 20% 800, ,
168
169
170 29.1% 28.5% 22.1% 9.9% 9.1% 7.3%
171 2,80020, % 2.4% % 85.9% 97.8% 67.2% 70.4% 65.5% State Pharmaceutical (Holdings) Limited
172 Frost & Sullivan II IMS 63.4% 65.6% 60.7% 44.1% 46.6% 46.5% 67.2% 70.4% 65.5% 7.9
173 Frost & Sullivan 10 Frost & Sullivan Frost & Sullivan31.3%39.3% Frost & Sullivan 4% Frost & Sullivan Frost & Sullivan %
174 19 GSP20
175 (i)(ii) ,055 1, % % % % %... 1, %
176 % 3.7% 5.8%
177 12, ,000 43,807
178 B. 107, , , ,920.04
179 19 11,735.8
180 II i) III ii) II III iii) II
181 1 II II III GMP
182 GMP II II III 171
183 46.68% (a) (b) (i) 10% (ii) 5% (i) (ii) 30% (a)
184 (b) (i) (ii) (i) (ii) (i) (ii) (iii) TPG 8.10TPG Star TPG Biotech (i) (ii)
185 (iii) (iv) (v) (vi) (vii) Golden Base
186 28NT Holdings (i) (ii) (iii) 20% 14A
187 %20% (i) (ii) (iii) A.34(1)
188 14A % 5% 14A.45 14A.47 14A 14A.35(1) 14A.35(2) 14A.36 14A.37 14A.38 14A.39 14A.40
189
190 Australian Business Lawyers H Allen Henry Moffitt 48TPG Growth Capital (Asia) LimitedTPG Morningside Technologies Inc LimitedMorningside Morningside Corporate Governance Award Organizing Committee Corporate Finance Committee
191 52 Solomon Systech (International) Limited J.P. Morgan Chartered Association of Certified Accountants Hong Kong Society of Accountants CEI Contract Manufacturing LimitedCEI Spencer Stuart & Associates Tristate Holdings Limited
192 MIT Corporation 60 Gairdner International Award Cresson Medal of Franklin Institute XII Sanremo International Award for Genetic Research (Distinguished Scientist Award from the Medical Research Council, Canada) Killam Prize of Canada Council European Cystic Fibrosis Society Award 35 The Thermal Controls Group 40
193 Smithkline Beecham Smithkline Beecham Glaxo Wellcome 36 Jabil Circuit, Inc. JBL
194 3.21 C3 B
195 A.193A.23 (a) (b) (c) (d)
196 10% (1) Golden Base (2) ,062, % 505,062, % TPG Star (3) ,250, % 146,549, % TPG Biotech (4) ,124, % 73,273, % (1) (2) Golden Base 50%Golden Base Golden Base Golden Base 50%Golden Base Golden Base (3) David Bonderman James CoulterTPG Star 146,549,000 ANT Holdings TPG204,250,170 TPG StarTPG Star, L.P. TPG Star, L.P. TPG Star GenPar, L.P. TPG Star GenPar, L.P. TPG Star GenPar Advisors, LLC TPG Star GenPar Advisors, LLCTPG Holdings I, L.P. TPG Holdings I, L.P. TPG Holdings I-A, LLC TPG Holdings I-A, LLCTPG Group Holdings (SBS), L.P. TPG Group Holdings (SBS), L.P. TPG Group Holdings (SBS) Advisors, Inc. TPG Group Holdings (SBS) Advisors, Inc.David Bonderman James Coulter (4) David Bonderman James CoulterTPG Biotech 73,273,000 ANT Holdings TPG102,124,830 TPG BiotechTPG Biotechnology Partners III, L.P. TPG Biotechnology Partners III, L.P. TPG Biotechnology GenPar III, L.P. TPG Biotechnology GenPar III, L.P. TPG Biotechnology GenPar III Advisors, LLC TPG Biotechnology GenPar III Advisors, LLCTPG Holdings I, L.P. TPG Holdings I, L.P. TPG Holdings I-A, LLC TPG Holdings I-A, LLCTPG Group Holdings (SBS), L.P. TPG Group Holdings (SBS), L.P. TPG Group Holdings (SBS) Advisors, Inc. TPG Group Holdings (SBS) Advisors, Inc. David Bonderman James Coulter
197 10%
198 626,250,000, , ,437, ,437, ,479, ,081,916, (a) (b) (c) (a) 20%
199 (b) (a) (b) (c) 10% (a) (b) (c)
200 ... 1,413,985 2,395,038 2,667, (1,178,904) (1,915,167) (2,004,775) (1) , , , ,196 7,670 28, (44,311) (1,739) 8, (108,129) (237,418) (354,456)... (43,147) (55,999) (90,056) (1)... 87, , , (14,277) (17,128) (45,379)... 73, , , (20,150) (58,087) (80,748)... 53, , , , , , (2)(3)... 53, , ,410 (1) 7.9 (2) 12.3 (3)
201 % % % , ,479, ,524, , ,230, ,167, , , , , , ,143, , , , , , , ,413, ,395, ,667, % % %... 90, , , , , , , , , , , , , , , , , , , , ,
202 % % %... 50, , , , , , , , , , , , , , , , , , , , , (21,789) (31,449) (59,317)... 87, , ,
203 , , , , , , ,514 1,213,754 1,738, ,262 55,990 47, , , , ,269 1,713,000 2,467, ,066 1,947,188 2,755, ,005 2, ,005 2, ,188 1,042,657 1,358, , , , ,000 6, ,823 54,931 51, ,508 1,608,307 2,250, ,390 1,610,312 2,253, , , , , , , ,130 15,130 15, , , ,277
204 ... (37,699) (251,274) (383,235)... (66,845) (63,019) (57,599) , , , , ,318 (62,730) %23.4%6.9% 10.7% 1 8.7% 1 II 64% II 54% 1 Frost & Sullivan II II II II
205 2 26,5003, % 3 1,250 20% 3 1, , % % 2 Frost & Sullivan 4
206 162 29% 28% 15.8%50.3% 1.6%5.2% 29% 28%
207 58.2% 43.2% 47.5% NT Pharma (Group) Co., Ltd. NT Pharma (Group) Co., Ltd. NT Pharma (Group) Co., Ltd. NT Pharma (Group) Co., Ltd 12.7% 18.9% 37.4% 8,500 I
208 614 III 74 II7.6% , , % 53.8% % 184.1
209 % 80.6% 19.3% 36.5%44.8% 54.1% 75.1%80.6% 22.6% 58.2%36.2% 43.2% 38.1% 47.5% II A+C
210 31.3%39.2% 4 II A+C Meningococcal ACYW 19.7% 13.9% 18.5% 4 Frost & Sullivan
211 8.4% 6.4% 7.4%
212
213
214
215 % 6.6% 1.6% % 2.2% 2.7%26.4%, 8.5% 8.6%
216 2.4% 4.7% 7.2% % % % , ,479, ,524, , ,230, ,167, , , , , , ,143, , , , , , , ,413, ,395, ,667,
217 Glipizide 26.4% 8.5% 8.6% 29.8% 22.4% 30.7%
218 % % % , ,310, ,302, , ,151, ,081, , , , , , , , , , , , , ,178, ,915, ,004, % % %... 1,163, ,912, ,982, (1)... 15, , , ,178, ,915, ,004, (1)
219 % % %... 90, , , , , , , , , , , , , , , , , , , , ,
220 % % %... 32, , , , , , , , , , , , , , , , , (1)... 17, , , , , , (1)
221 % % %... 10, , , , , , , , , , , , , , , , , , , (1)... 12, , , , , , (1) % % %... 50, , , , , , , , , , , , , , , , , , , , , (21,789) (31,449) (59,317)... 87, , ,
222 , , , (25,674) (37,380) (96,163)... 48,196 7,670 28, (44,311) (1,739) 8, (14,277) (17,128) (45,379)... 73, , , NT HoldingsTPG AA NT Holdings ANT Holdings NT Holdings NT Holdings NT Holdings A A TPG
223 ... 73, , , ,429 41,228 56, ,427 21,895 28, (17) (1)... (9,219) (5,348) (7,901)... 3,086 2,684 4, (3,294) (1,115) ,150 58,087 80,748 25% 5% 10% 10% 25% 25%
224 % 33.1% 38.4% % 25% 15% 25% 25%
225 ... 1,413, ,395, ,667, (1,178,904) (83.4) (1,915,167) (80.0) (2,004,775) (75.1) , , , , , , (44,311) (3.1) (1,739) (0.1) 8, (108,129) (7.6) (237,418) (9.9) (354,456) (13.3)... (43,147) (3.1) (55,999) (2.3) (90,056) (3.4)... 87, , , (14,277) (1.0) (17,128) (0.7) (45,379) (1.7)... 73, , , (20,150) (1.4) (58,087) (2.4) (80,748) (3.0)... 53, , , , % 2, , %1, , %1,167.8
226 %356.8 Meningococcal ACWY A+C A+C 2.0% 0.9% 18.8% 6.7% 6.1% 2.3% %1, % %304.9
227 1, % 2, % % 24.9% % % 14.6% % % 7.4% % % 38.1% % % 38.6% %398.6
228 43.2% 47.5% % % % % 13.3% % % 3.4%
229 % 9.6% % % % % % %
230 % 80.7(i) (ii) (iii) 33.1% 38.4% % % 1, % 2, %1, %1, %
231 % % % % , % 1, % % 20.0%
232 % % 11.5% % % 6.4% % % 36.2% % % 33.9% % % 43.2% % % 13.9%
233 % % % 9.9% % % 2.3% % % 8.0% %107.3
234 % % % % % % % % 4.9%
235 74 Frost & Sullivan II 7.6% 1,
236 19.0% 26.2% 30.5%... 64,884 66, , (37,699) (251,274) (383,235)... (66,845) (63,019) (57,599) , , , , ,318 (62,730)... 66, , , (i) 298.1(ii) 525.4
237 (iii) (i) (ii)646.3 (iii) (i) 43.5 (ii)236.8 (iii) (i) 72.1 (ii) 27.1
238 378.1 (i) (ii) (i) (ii) (i) 35.2(ii) , , , , ,514 1,213,754 1,738,213 1,746, ,262 55,990 47,080 45, , , , , ,269 1,713,000 2,467,260 2,393, ,188 1,042,657 1,358,270 1,284, , , , , ,000 6, ,823 54,931 51,941 54, ,508 1,608,307 2,250,398 2,175, , , , ,681
239 ,560 9,899 7, ,221 3,472 1, , , , , , , (i) (ii)
240 (iii) % %231.0 % % % , , , , , , , , , , , , , , % (1) (1) ,236, (i) (ii) (iii)
241 ,403 1,083,657 1,544, ,870 27,162 22, ,755 99, , ,486 2, ,514 1,213,754 1,738,213 % % % , , , , , , , , , , , , , , , ,110, ,566,
242 42.4% 57.6% % % , , , , , , , , , , , , , , , , , ,566,710 % % , , , , , , , , , , , , , , ,110,819 % % , , , , , , , , , , , , , , , , , , ,110.8
243 1,566.7(i)(ii) (iii) % 2.4% % 120
244 ,566.7 ) % ,783 49, , , ,566, , % %... 8, , , , , , , , , , , , , , , , a % b. 41
245 c. d. e. 15.9% b c d e f. g. h i ,194 5,030 13, ,238 3, (164) (3,782)... 5,030 13,268 12,595
246 (1) (1) ,972, (i) (ii)
247 , , , , , , ,564 69, , ,094 18, ,379 7,559 13, ,351 21, ,188 1,042,657 1,358,270
248 (%) (%) (%) , , , , , , , , , , , , , , , (1) (1) ,499,
249 % NT Holdings 28(c) ,000 25, , , , , , , ,103 5, , , , ,684
250 , , , , , , , ,845 52, ,441 6, , , , ,262 45,562 25, , , , NT Holdings 24
251 % %
252
253 ... 7,965 7,456 6, ,137 6,831 3, ,102 14,287 9, ,353 13,864 10, ,693 10,184 56,046 24,048 10,883
254 5.9% 0.7% 3.3% % 7.0% 5.0% 27.0% 21.0% 13.8%
255 % 129, % 365, % 690, % 5.91% 6.12% % 70, % 6, , , , % (42,410) 0.75% (36,845) 2.22% 129, , , % 1.95% 2.11% 5.18% 56, % 75, % 142, % 0.36% 0.01% 1.71% (51,262) 1.71% (13,580) 1.91% (10,235) % 0.01% 0.01% 0.36% (67,803) 0.36% (212,240) 0.36% (154,913) (62,325) (150,304) (22,375) , , , , ,000 42,000
256 5% %
257 ,081,916,
258
259 1, % % %
260 10% % % %
261 (1) (a)
262 (b) (c) (d) (e) (f) (g) (h) (i) (j) (k) (l) (m)
263 (n) (1) (2) (3) (4) (2) (a) (b) (c) (d) (e)
264 (f) (g) (a) (b) (c) (a) (b) (d) (a) (b) (c) (a) (b) (c) (a) (b) (c)
265 (a) (b) (c) (i) (ii) (iii)(i) (ii)(iv) (i) (ii) (iii) (i) (ii) (iii) (a)(i) (ii) (iii) (a)(i) (ii) (iii) TPG (i) (ii)
266 (iii)(i) (ii) (iv) (i) (ii) (iii) (i) (ii) (iii) (a) 10.07(2) (b) (a) 155 (b) 3% 1%
267 ,554,000 15%
268 (a) 35,703,500 (b) 144A 321,328,500 35,703,500 10% (i) (ii) 3.3%
269 A B A 17,852, B 17,851, AB AB 17,851,500 (i) 15 50(ii) (iii) ,110,000(i) 142,813,000(ii) 178,516,000(iii) 30% 40% 50% A B
270 ,328, ,775,500 86,553,000 90%
271 30 40,571,50012,982,500 53,554,000 15% 4.77% (a) (b) (c) (a) (b) (d)
272 (e) (f) (b) (c) (d) (e) 30 53,554,000 15% Golden Base TPG Golden Base TPG 53,554,00015% Golden Base TPG 10.07(1)(a)
273 10.07(3)(a) (b) Golden Base TBG Golden Base TBG 1% 0.003%0.005%
274 10% ,256.0
275 (a) (b) (c)
276 (i) (ii) (i) (ii)
277 (i)(ii) (iii) 18 S (
278 1. (1)
279 (2) B (3) (4)
280 (a) (b) (c) (d) (a)
281 (b) (i) (ii) (c) (i) (ii) (d) (i) (ii) 2. eipo
282
283 ( (a) (b)
284
285
286 E (i) (ii) 4.
287
288 17,851,50050% % 0.003% 0.005%500 3, ,851,500
289 6. 1% 0.003%0.005% 1% 0.003%0.005% % 0.003%0.005% 7.
290 (1) (1) (1) (1) (1) 1 24
291
292 10. (a) ( ( ( E ( (
293 (b) (c) (d) (
294 50% (a) (i) (ii) (b) (i) (ii) (iii) 1% 0.003%0.005%
295 (c) 1% 0.003%0.005% (a) 1,000,
296 1,000,0001,000,000 (b) 1,000,000 1,000,000 1,000,000
297 (c) 1,000, ,000,000 (d)
298
299 A NT Pharma (Group) Co., Ltd. Kimford Investment Limited Goldwise Resources Limited Tai Ning Pharmaceutical (Investment) Company Limited Farbo Investment Limited Humford Limited
300 C 31 AC A
301 A NT Pharma (Group) Co., Ltd. NT Pharma (Group) Co., Ltd. NT Pharma (Group) Co., Ltd. B NT Pharma (Group) Co., Ltd. B NT Pharma (Group) Co., Ltd.
302 NT Pharma (Group) 2 100% Co., Ltd. Kimford Investment Limited 1 100% Kimford Goldwise Resources Limited 1 100% Tai Ning Pharmaceutical 1 100% (Investment) Company Limited Farbo Investment Limited 1 100% Humford Limited 1 100% NTP (China) Investment 15,000, % Co., Limited NT Pharma (HK) Limited 2 100% 2,000, % 100% 10,000, % 20,000,000 3,370, % 100% 100,000,000
303 100% 50,000,000 80% (i) 55,625,000 11,851, % 100% 166,600, , % 20,030, % (i) 80%Kimford Kimford % Kimford , ,000
304 B 1 C ,413,985 2,395,038 2,667, (1,178,904) (1,915,167) (2,004,775) , , , ,196 7,670 28, (44,311) (1,739) 8, (108,129) (237,418) (354,456)... (43,147) (55,999) (90,056)... 87, , , (a) (14,277) (17,128) (45,379) , , , (a) (20,150) (58,087) (80,748)... 53, , , , , , , , ,410
305 , , , ,284 (86) 11, , , , , , , , , ,395
306 3 C , , , ,633 15,309 32, , , , ,441 10,444 2, ,908 39,904 37, ,250 1,250 1, (b) 899 3,812 5, , , , , , , ,514 1,213,754 1,738, ,262 55,990 47, , , , ,269 1,713,000 2,467, ,188 1,042,657 1,358, , , , ,000 6, (a) 12,823 54,931 51, ,508 1,608,307 2,250, , , , , , ,
307 C... 21(b) , , , , , , , , , , , ,130 15,130 15, , , ,277
308 4 24(b) 24(c)(i) 24(c)(ii)24(c)(iii) 24(c)(iv)... 22,528 28,336 8,256 72, ,999 15, , ,263 53,263 53, ,284 15,284 15, ,284 53,263 68,547 68, ,195 (8,195)... 37,812 36,531 8, , ,546 15, , , , , (86) (86) (86)... (86) 117, , , ,116 4,116 4, ,370 (8,370)... 37,726 44,901 8,256 4, , ,746 15, , , , , ,985 11,985 11, , , , , (800) (800)... 24,806 24,806 24, ,458 (20,458)... 49,711 65,359 8,256 28, , ,147 15, ,
309 5 C... 73, , , (1,722) (1,186) (619)... 3 (45,980) , (527) , (a) 14,277 17,128 45, (b) 4,116 24, (c) (c) 4,595 4,117 4, (c) 6,096 4,864 12, ,627 (127) , , , (43,499) (105,326) (298,095)... (236,758) (646,267) (525,400) , , , (31,069) (233,505) (298,355)... (8,115)... (6,630) (17,769) (76,765)... (37,699) (251,274) (383,235)
310 C... (72,055) (63,619) (51,167)... (17,528)... (27,087) (4,113) (1,680)... 1, , ,722 1, ,503 (4,728) 8, ,494 8, (66,845) (63,019) (57,599) ,095 2,067,928 2,085, ,000 16, (619,268) (1,812,853) (1,696,263)... (80,000)... (14,277) (17,128) (45,379) , ,664 98, (800) , , , , ,318 (62,730)... 64,884 66, , (1,607) (12) , , ,810
311 C 1 (a) C (b) A (c)
312 29 (d) (e) (i)
313 (ii) (ii) (i) 1(j) (f) 1(j) (g) 1(j) 1(v)
314 (h) (i) 1(j) 10 (ii) 1(j) 32 (iii) GSP GSP 1(j) (iv) 1(j) 10 (v) 1(j) (vi) 1(j) 5 10
315 (i) (j) (i)
316 (ii)
317 (k) (l) 1(j) (m) (n) (o)
318 (p) (i) (ii) (q)
319 (i) (ii)
320 (r) (i) (i)(ii) 1(r)(ii) (ii) (s) (i)
321 (ii) (iii) (iv) (t) (u) (v)
322 (w) (i) (ii) (iii) (iv) (v) (i) (vi) (x) ,380,405 2,281,867 2,475, , , ,650 1,413,985 2,395,038 2,667,978
323 10 10% (a) ,722 1, , ,076 25, ,812 48,196 7,670 28, (20,259) (619) (16,493)... (7,559) (1,120) 7,621 (44,311) (1,739) 8,148
324 5 (a)... 14,259 12,980 36, ,325 5,507 9, ,584 18,487 45,982 *... (2,307) (1,359) (603) 14,277 17,128 45,379 * 6.14% 8.22% 5.35% 8.22% 5.35% 5.84% (b)... 7,248 10,921 19, ,409 73, , ,116 24,806 56,657 89, ,746 10% 22%
325 5% 20,000 (c) ,595 4,117 4, ,096 4,864 12, ,071 8,443 8,327 14(b)... 1,163,757 1,912,316 1,982,422
326 6 (a) , , ,277 55,204 70, ,453 56,127 70, (1,790) (1,451) (1,790) (1,451) ,150 58,087 80,748
327 (b)... 73, , ,158 (i) (ii) (iii)... 19,429 41,228 56, ,427 21,895 28, (17) (1) (iii)... (9,219) (5,348) (7,901)... 3,086 2,684 4, (3,294) (1,115) ,150 58,087 80,748
328 (i) (ii) 16.5% (iii) 33% 25% 15% 15% 15% 25% 18% 20% 22% 24% 25% 9% 10% 11% 24% 25% (iv) 10% 25%5%
329 7... 5, , , ,665
330 ... 2, , , ,008
331 ... 3, , ,702 4, ,126 4, ,702 7,913 1(p)(ii) 8
332 ,221 2,894 2, ,331 5,285 2,360 4,343 7, ,000, ,000,001 1,500, ,500,001 3,000, ,000,001 3,500, A
333 10 (a)
334 ,334 1,230,340 1,167,767 89, , , , , , , , ,861 1,413,985 2,395,038 2,667, (770,613 ) (1,151,063 ) (1,081,478 ) (68,981 ) (159,090 ) (220,917 ) (76,915 ) (355,457 ) (439,919 ) (262,395 ) (249,557 ) (262,461 ) (1,178,904 ) (1,915,167 ) (2,004,775 )... 70,721 79,277 86,289 20,112 90, , , , ,643 37,104 40,201 42, , , , ,626 47,100 44,970 9,771 60,216 64,888 46, , ,741 12,862 13,119 10, , , , ,874 4,628 7,421 2,916 2,002 4,026 9,105 6,980 12,025
335 (b)... 1,413,985 2,395,038 2,667, , , , (25,674) (37,380) (96,163)... 48,196 7,670 28, (44,311) (1,739) 8, (14,277) (17,128) (45,379)... 73, , ,158
336 ,324 22, ,457 3,869 3,926 14,435 71,673 33, , (9) (81) (19) (65) (174) (174) , ,592 60,614 60, (18,472) (12,800) (127) (31,399) (17,376) (48,775)... 2,852 10, ,416 4,241 4,378 68, ,714 16, , ,443 6, ,314 1,893 1,660 17,582 1,104 18, (2) (15) (11) (40) (68) (68)... 1,437 2, , , (4,376) (5,072) (114) (9,562) (883) (10,445) , ,152 2,597 2,138 14, , ,348 7, ,264 1,644 2,240 68,027 86,666 15, ,299
337 ... 2,852 10, ,416 4,241 4,378 68, ,714 16, , , ,818 1, ,398 82,539 82, (12) (1,173) (651) (78) (1,914) (1,914)... 93,445 15,558 (109,003)... 96,297 28, ,062 5,541 4,404 35, ,341 16, , , ,152 2,597 2,138 14, , , , , , (5) (642) (345) (48) (1,040) (1,040) , ,430 2,983 2,767 17, , ,661 23, ,632 2,558 1,637 35, ,469 15, ,778
338 ... 96,297 28, ,062 5,541 4,404 35, ,341 16, , (6) (38) (12) (52) (108) (108)... 4,088 1, ,957 1,570 3,179 48,027 60,844 17,528 78, (2,851) (367) (32) (701) (3,951) (3,951)... 46,307 13,699 (60,006) ,841 43, ,981 7,067 6,830 23, ,126 33, , , ,430 2,983 2,767 17, , (3) (6) (8) (28) (45) (45)... 5,209 3, , ,166 12, , (649) (6) (576) (1,231) (1,231)... 5,196 8, ,460 3,738 3,329 29,267 1,229 30, ,645 35, ,521 3,329 3,501 23, ,859 32, ,336
339 (a) (b) 73,583, ,826, ,372,000 (c) 93,445, ,136, GSP... 7,283 9,330 7, ,663 26, (32) (32)... 30, , , , , , , , ,456 6, , ,332 1, , , , , , , ,099 7,030 29, ,315 42,908
340 GSP... 7,283 9,330 7,030 30, ,750 56, , , , , , , , , ,184 9,330 1,000 1,435 13, , , , , , , , ,371 7,030 26,000 1,224 1,279 39,904 GSP... 7,283 9,330 7,030 30,000 1,224 3,103 57, (17) (17)... 1,680 1, , , , , , , , ,912 9,330 4,000 1,824 18, , , , , , , , ,643 7,030 23,000 1,207 2,294 37,174
341 (a) (b) (c) GSP GSP GSP 15.6% 16.2% 14.2% ,250 1,250 1, ,250 1,250 1,250
342 % % % (a)... 2,560 9,899 7, ,221 3,472 1, , , , , , ,054 20,845,000 52,971,00019
343 (b)... 1,161,315 1,908,591 1,977, ,442 3,725 5,114 1,163,757 1,912,316 1,982, ,303 1,124,087 1,579,305 15(b)... (5,030) (13,268) (12,595) 534,273 1,110,819 1,566, ,755 99, , ,486 2, ,514 1,213,754 1,738,213 1,720,000 1,576, ,000 66,339, ,672, ,694,00019
344 (a) , , , , , , ,580 44, , ,214 10, , , , ,273 1,110,819 1,566, (a) (b) 1(j)(i)... 5,194 5,030 13, ,238 3, (164) (3,782)... 5,030 13,268 12,595
345 5,742,000 14,375,000 17,541,000 5,030,000 13,268,000 12,595,000 (c) , , , , , , ,084 43,793 87, ,449 20, , , ,428 95, , , ,561 1,109,712 1,561, ,000,000 96,720, ,712,
346 , , , (869) (5,103)... 66, , ,810 67,136, ,870, ,785, , , , ,564 69, , ,094 18, ,379 7,559 13, , , , ,351 21, ,188 1,042,657 1,358,270
347 , , , ,438 31, , ,856 2,007 6, ,301 1,676 69, , , , , , ,687
348 , , , , , ,000 25, , , , , , , , ,600, ,188, ,380, ,497, ,870, ,579, , , , ,441 6, ,845 52, , , , ,262 45,562 25, , , ,226 72,600,000Rich Great International Industries LimitedRich Great Rich Great
349 181,446,000 Rich Great NT Pharma (Holdings) Company Limited 587,776,000 NT Pharma (Holdings) Company Limited 28,116,000 25(c) % 21 (a)... 3,750 7, ,823 51,181 44,724 12,823 54,931 51,941
350 (b)... 3,089 (2,080) (1,780) 61 (710)... (4) (4)... (276) (57) ,813 (1,634) (1,196) (17)... 2,813 (1,634) (1,196) (17)... (73) (2,913) 1,196 (1,790)... 2,740 (4,547) (1,807)... 2,740 (4,547) (1,807)... (79) (1,372) (1,451)... 2,661 (5,919) (3,258)... (899) (3,812) (5,919) ,005 2,661 (17) (1,807) (3,258)
351 (c) 1(q) 29,428,000 18,689,000 33,363, ,000 6,508,000 6,274,000 18,967,000785,000 (d) 80,329, ,386, ,718, , , (45,980)... 45,980, NT Pharma (Holdings) Company LimitedNT Holdings NT Holdings NT Holdings
352 NT Holdings NT Holdings (a)... 19,335, ,335, ,335, ,582, ,582, ,582, ,666, ,666, ,666, ,166, ,166, ,166, , , , , , , , , , ,055,723
353 (b)... 58,007, ,007,799 42,047, (10,141,366)... 58,007,799 89,914, ,412,341 NT Holdings58,007, NT Holdings88,714, ,200,000 70% (c) % % 58.23% 58.00% 59.51% 58.94% 53.10% 57.19%... 0% 0% 0% 0% 0% 0% 0% % 4.378% 4.293% 4.072% 3.415% 3.241% 3.858%
354 24 (a) (b) NT Pharma (Group) Co., Ltd , ,250,000, NT Pharma (Group) Co., Ltd (c) (i) 1(u) (ii) 10% 50%
355 (iii) (iv) NT Holdings 1(p)(ii) (d) 19.0% 26.2% 30.5% 25 (a) (i)
356 9.2% 7.0% 5.0% 27.0% 21.0% 13.8% 27 (ii) (b) , , ,628
357 ,002 4,183 10, , , ,689 3,266 7, , ,584 (c) (i) (i) 4.86% 1.06% 2.05% % 129, % 365, % 690, % 70, % 6, , , , % % (42,410) 2.22% (36,845) 129, , ,
358 1.70% 1.95% 2.11% % 56, % 75, % 142, % 0.36% 0.01% % (51,262) 1.71% (13,580) 1.91% (10,235) 0.13% 0.01% 0.01% % (67,803) 0.36% (212,240) 0.36% (154,913) (62,325) (150,304) (22,375) , , ,194 (ii) , ,000 42,000 (d)
359 (i)... 26, ,262 42,409 25, ,617 40,550 5, (34,784) (81,771) (93,140) (22,746) (69,557)... (92,097) (72,706) 22,095 (64,648) (93,140) (65,134) (69,557) (ii)... 5% 829 5% (2,424) 5% (2,443) (5)% (829) (5)% 2,424 (5)% 2, % 5% (3,493) 5% (2,608) (5)% (5)% 3,493 (5)% 2,608
360 (e) 26 (a)... 43,353 13,864 10, ,693 10,184 56,046 24,048 10,883 (b)... 7,965 7,456 6, ,137 6,831 3,340 17,102 14,287 9,709
361 27 Rich Great Rich Great 15,401, Rich Great International Industries Limited NT Pharma (Holdings) Company Limited (a)... 9,873 15,161 13,106
362 (b) ,219 7,814 10, ,270 13,421 9,219 10,084 23,507 5(b) (c) NT Pharma (Holdings) Company Limited... 2,476 2, ,010 3,486 2, NT Pharma (Holdings) Company Limited , , ,955 Rich Great International Industries Limited... 2, ,259 6, , , , ,351 21,363
363 NT Pharma (Holdings) Company Limited NT Pharma (Holdings) Company Limited 60 (d)... 72, , ,775 (e) NT Pharma (Holdings) Company Limited , ,775 (f) 72,600,000 60,314,000Rich Great Rich Great Rich Great 29
364 (a) (b) (c) (d)
365 NT Pharma (Holdings) Company Limited 31 NTP (China) Investment Co., Limited NT Pharma (HK) Limited
366 32 8 1(a) (2010)
367 33 (a) (b) 29% 28% D
368 4.29 A (6) (2) (3) (4)(5) (6) , ,414 1,356, ,543 1,229,966 1,679, (1) 487,147,000 1,250,000 37,174, ,000
369 (2) (3) NT Pharma (Holdings) Company Limited (4) 1,081,916,500 (5) (6) B. (1)(3) (2)(3) (1) (2) 1,081,916,500 (3)
370 C
371 (1)
372 a) b) c) 4.29(1)
373 A. B. C.
374
375 4.
376
377
378 MRICS MHKIS MSc(e-com) MRICS MHKIS MSc(e-com)
379 1. 80% 16,500,000 13,200,000 19,550,000 15,640, % 19,260,000 19,260,000 22,820,000 22,820,000 35,760,000 32,460,000 42,370,000 38,460,000
380 3. 100% % % % % % 289
381 9. 100% % % C % C % 2 B 5 H %
382 % % % % % 16 C 2508
383 % 16 C % ,760,000 32,460,000 42,370,000 38,460,000
384 1. 49, ,500, , ,550,000 80% 13,200,000 15,640, , ,499, (2006) , C , ,323
385 , ,500,000126,180,000 80%85,200,000100,940, % 8. (i) (ii)
386 2. 57, ,260, , ,820, % 19,260,000 22,820, , ,676, (2009) , C , , , ,000,000
387 8. 31,400,00037,200, (i) (ii)
388 , , , (i) (ii) (iii)
389 , (i) (ii)
390 , (i) (ii)
391 6. 1, , (i) (ii)
392 , , (i) (ii) (iii)
393 , , (i) (ii)
394 , (i) (ii)
395 , (i) (ii)
396 C 1 17, (i) (ii)
397 C 1 1, (i) (ii)
398 B 1, H1 8, (i) (ii)
399 , , (i) (ii)
400 , (i) (ii)
401 , (i) (ii)
402 , (i) (ii)
403 , (i) (ii)
404 C , (i) (ii)
405 C , (i) (ii)
406 21. Holita Company Limited , , Holita Company Limited 2. UB
407 TPG TPG NT Holdings TPG TPG TPG TPG Star TPG Biotech NT Holdings TPG StarSing WangNT Holdings TPG BiotechKen LinNT Holdings TPG Star TPG Biotech Lin WangNT Holdings TPG NT Holdings NT Holdings NT Holdings NT Holdings A NT HoldingsTPGA NT Holdings(a) (b);(c) ;(d) NT Holdings A ;(e);(f) NT Holdings ;(g) ;(h) (i)(j) (k)nt Holdings (l)(m) (n)(o) NT Holdings
408 TPG TPG(a) (b)nt Holdings NT Holdings(a) (b) TPG NT Holdings NT Holdings TPG(a) 90NT Holdings (b) 30NT Holdings (c)15nt Holdings (d)nt HoldingsTPGNT Holdings TPGTPGNT Holdings NT HoldingsNT Holdings NT Holdings TPGNT Holdings NT Holdings TPG NT HoldingsNT Holdings TPG NT Holdings NT Holdings (i)nt Holdings (ii) TPGNT Holdings TPGNT Holdings 50.1% NT Holdings NT HoldingsTPG NT HoldingsNT Holdings 500NT Holdings 125
409 TPG TPG NT Holdings NT Holdings 50%TPG TPG 180 NT Holdings NT Holdings 1%TPGNT Holdings NT Holdings 1% TPGNT HoldingsNT Holdings Golden BaseNT Holdings ,500,000TPG NT Holdings NT Holdings TPGTPGTPG TPG A TPGNT Holdings NT Holdings TPGNT Holdings NT Holdings TPG NT HoldingsNT Holdings Golden BaseTPG ATPG TPGA NT HoldingsTPGA TPG NT HoldingsTPGNT Holdings (1)NT Holdings (2)NT Holdings
410 TPG (3)NT Holdings A (1)125% (2) (3) (a) 125% (b) 12.5% TPGA ANT Holdings A A A NT Holdings NT Holdings TPG A A NT HoldingsANT Holdings AA NT Holdings 165 A TPGNT Holdings NT Holdings TPG A NT Holdings [TPGA TPG NT Holdings B ] 100% B612,320, ,000,000 NT Holdings 250 ATPGNT Holdings NT Holdings TPG A NT Holdings [ B ] 100% B612,320,
411 TPG TPG NT HoldingsTPG A (1%)NT Holdings 1,142, ,576 TPGA (a) TPG A2% (b) TPG A5% TPGNT HoldingsA NT Holdings NT Holdings 4 NT Holdings 3,067,123 1,954,621 TPG TPG NT Holdings ATPG NT HoldingsTPGNT Holdings TPGTPG A 30 NT Holdings A (a) (b)tpg A 125% TPG TPGNT HoldingsNT Holdings NT Holdings NT Holdings NT Holdings NT Holdings NT Holdings NT Holdings
412 TPG
413 TPG Golden BaseTPG TPG TPG TPG 1 [A + ( x ) ] x 0.36/A A 344,000,000 B x B Golden BaseTPG TPG TPG TPGTPG A TPG Biotech TPG Star TPG
414 22 1. (a) 27(2) (b) 2. (a) (i)
415 (ii) (iii) (iv) (v)
416 (aa) (bb) (cc) (dd) (ee) 5% (ff)
417 (vi) (vii)
418 (aa) (bb) (cc) (6) (dd) (ee) (ff)
419 (viii) (ix) (x) (30) (b) (c) (i) (ii) (iii) (iv)
420 (v) (d) (e) (21) (10) (95%) (21)(10) (15)
421 (f) (g) (15)(18) (h)
422 (21) (i) (21)(20) (e) (21) (10) (14) (10)
423 (i) (ii) (95%) (aa) (bb) (cc) (dd) (ee) (ff) (20%) (gg) (j)
424 (30) (k) (l)
425 (m) (i) (ii) (a) (b)
426 (n) (o) 20 (14)
427 (20) (p) (2) (q) (r) 3(f) (s)
428 (i) (ii) (t) (i) 12(ii)12 (iii) (3) (u)
429 3. (a) (b) (a) (b)(c) 37 (d) (e) (f) (c)
430 (d) (e) (m)
431 (f) (a) (b) (c) (a)(b) (c) (d) (g) (h) (i) (ii) (iii)
432 (i) (j) (1) (2) (20) (k) (l) (m) (n)
433 (28) (21)
434 (o) (75%) (p) (4) (90%)(4) (2) (1) (q) 4. Conyers Dill & Pearman
435 A. 1. Cricket Square, Hutchins Drive, PO Box 2681, Grand Cayman, KY1-1111, Cayman Islands XI 2. 50, ,250,000, (a) 5 50 (b) NT Holdings , A 125, A 908,500, ,125, A
436 (c) (a) (b) 30(i) (ii) (iii) (1) (2) 20% (3) 10% (4) (3)
437 (2) (2) (3) (4) (i) (ii) (iii) 4. (a) (b) 10% (i) (ii) (iii) (c)
438 (d) (e) (f) 1,081,916, ,191,650 (g) 26
439 B. 1. (a) TPG Star TPG Biotech NT Holdings, (b) NT Holdings TPG Star TPG Biotech (c) Golden Base TPG Star TPG Biotech (d) Golden Base Golden Base (e)
440 2. (a) (i)
441 NT Pharma (Holdings) Company Limited (b) ntpharma.hk... ntpharma.cn... NTP (China) Investment Co., Ltd ntpharma.com.cn... NTP (China) Investment Co., Ltd ntpharma.com... NTP (China) Investment Co., Ltd.com... NTP (China) Investment Co., Ltd.com... NTP (China) Investment Co., Ltd.com... NTP (China) Investment Co., Ltd... NTP (China) Investment Co., Ltd.... NTP (China) Investment Co., Ltd... NTP (China) Investment Co., Ltd
442 C. 1. XV XV (1) (2) (3) ,062,500(L) 46.68% (4) ,062,500(L) 46.68% (1) L (2) (3) 505,062, % Golden BaseGolden Base (4) 505,062, % Golden BaseGolden Base
443 2. XV2 3 (1) Golden Base ,062,500(L) 46.68% (2) ,062,500(L) 46.68% (3) ,062,500(L) 46.68% TPG (4) ,822,000(L) 20.32% (1) L (2) 505,062, % Golden BaseGolden Base (3) 505,062, % Golden BaseGolden Base (4) David Bonderman James CoulterTPG Star 146,549,000 TPG Biotech 73,273,000 ANT Holdings TPG306,375,000 TPG StarTPG Star, L.P.TPG Star, L.P. TPG Star GenPar, L.P. TPG Star GenPar, L.P. TPG Star GenPar Advisors, LLC TPG Star GenPar Advisors, LLCTPG Holdings I, L.P. TPG Holdings I, L.P. TPG Holdings I-A, LLC TPG Holdings I-A, LLCTPG Group Holdings (SBS), L.P. TPG Group Holdings (SBS), L.P. TPG Group Holdings (SBS) Advisors, Inc. David Bonderman James Coulter TPG BiotechTPG Biotechnology Partners III, L.P. TPG Biotechnology Partners III, L.P.TPG Biotechnology GenPar III, L.P. TPG Biotechnology GenPar III, L.P. TPG Biotechnology GenPar III Advisors, LLC TPG Biotechnology GenPar III Advisors, LLCTPG Holdings I, L.P. TPG Holdings I, L.P. TPG Holdings I-A, LLC TPG Holdings I-A, LLCTPG Group Holdings (SBS), L.P. TPG Group Holdings (SBS), L.P. TPG Group Holdings (SBS) Advisors, Inc. David Bonderman James Coulter
444 3. (a) (b) D. NT Holdings NT Holdings 90,614,362 NT Holdings NT Holdings 89,914,357
445 NT Holdings % ,357,19570% 600,000 (a) (b)
446 NT Holdings NT Holdings TPG (c) (d) (e) 45,307, % 44,957, %
447 (f) 10 (a)33.33% (b) 50%(c) 100% (g) (i) (ii) (iii) (iv) (i) (ii) (v) (vi) (iv) (i)
448 (ii) (h) (i) (j) (i) (a) (b) (c)
449 (ii) (A) (B) (C) (D) (k) (l) 10 (m)
450 (n)... 5,627, ,875,775 1,875,775 1,875, E... 3,900, ,679 1,300,000 1,300, , A... 3,500, ,045,350 1,166,667 1,166, , ,500, ,333 1,166,667 1,166, , ,800, , , , , C... 2,800, , , , , ,000, , , , ,500, ,333 1,166,667 1,166, ,333 3,500, ,250, , , , ,773 1,250, AA... 1,000, , , , ,997 1,000, ,479, ,498,588 5,693,264 5,693,254 2,194, , , , ,000 70% 70% 70%... 44,957,195
451 5% (i) (ii) (o) 17.02(1)(b) 1A (1)(b)I10 (i) (ii) 17.02(1)(b)1A 27 (i) D. 10(d) 17.02(1)(b)1A 27
452 (ii) (i) (1)(2) (3)(4) (iii) (iv) D. (v) 17.02(1)(b)1A 27 I10 (vi) 342AI10(d) (i) D. 10(d) (ii) (i) (1)(2) (3)(4) (iii) I10
453 E , Conyers Dill & Pearman Conyers Dill & Pearman 6. 44A 44B
454 7. 3A.193A L 4 F A.34(1) (1)(b)1A 27 I 10(d) 17.02(1)(b)1A AI10(d)
455 G. TPG Biotech (1)... PO Box ,851,830 4,328,000 Ugland House South Church Street George Town Grand Cayman KY Cayman Islands TPG Star (2)... PO Box ,701,170 8,654,500 Ugland House South Church Street George Town Grand Cayman KY Cayman Islands (1) David Bonderman James CoulterTPG Biotech 73,273,000 ANT Holdings TPG102,124,830 TPG BiotechTPG Biotechnology Partners III, L.P. TPG Biotechnology Partners III, L.P. TPG Biotechnology GenPar III, L.P. TPG Biotechnology GenPar III, L.P. TPG Biotechnology GenPar III Advisors, LLC TPG Biotechnology GenPar III Advisors, LLCTPG Holdings I, L.P. TPG Holdings I, L.P. TPG Holdings I-A, LLC TPG Holdings I-A, LLCTPG Group Holdings (SBS), L.P. TPG Group Holdings (SBS), L.P. TPG Group Holdings (SBS) Advisors, Inc. TPG Group Holdings (SBS) Advisors, Inc. David Bonderman James Coulter (2) David Bonderman James CoulterTPG Star 146,549,000 ANT Holdings TPG204,250,170 TPG StarTPG Star, L.P. TPG Star, L.P. TPG Star GenPar, L.P. TPG Star GenPar, L.P. TPG Star GenPar Advisors, LLC TPG StarGenPar Advisors, LLCTPG Holdings I, L.P. TPG Holdings I, L.P. TPG Holdings I-A, LLC TPG Holdings I-A, LLCTPG Group Holdings (SBS), L.P. TPG Group Holdings (SBS), L.P. TPG Group Holdings (SBS) Advisors, Inc. TPG Group Holdings (SBS) Advisors, Inc. David Bonderman James Coulter
456 H. (a) (b) (c) (d) (e) (f) (g)
457 1. (i) (ii) (iii) E. 5.(iv) (a) (b) (c) (d) (e) (f) (g) (h) Conyers Dill & Pearman (i) (j) B1 (k) 5 (l) (m) (n)
458 China NT Pharma Group Company Limited 中國泰凌醫藥集團有限公司
China Xinhua Education Group Limited 400,000,000 40,000, ,000, % % 0.005% C
CHINA XINHUA EDUCATION GROUP LIMITED 中國新華教育集團有限公司 於開曼群島註冊成立之有限公司 股份代號 02779 全球發售 獨家保薦人 聯席全球協調人 聯席賬簿管理人及聯席牽頭經辦人 China Xinhua Education Group Limited 400,000,000 40,000,000 360,000,000 3.69 1.0% 0.0027%
Differ Group Holding Company Limited 250,000, % 0.003% 0.005% C
Differ Group Holding Company Limited 鼎豐集團控股有限公司 Differ Group Holding Company Limited Differ Group Holding Company Limited 鼎豐集團控股有限公司 於開曼群島註冊成立的有限公司 股份代號 8056 配售 鼎豐集團控股有限公司 保薦人 聯席賬簿管理人及聯席牽頭經辦人 按英文首字母排序
LAP KEI ENGINEERING (HOLDINGS) LIMITED 320,000, ,000, ,000, % % 0.005% C
Lap Kei Engineering (Holdings) Limited 立基工程 控股 有限公司 於開曼群島註冊成立的有限公司 股份代號 8369 配售 保薦人 賬簿管理人兼牽頭經辦人 LAP KEI ENGINEERING (HOLDINGS) LIMITED 320,000,000 192,000,000 128,000,000 0.25 1% 0.0027% 0.005% 0.01 8369
JINTIAN PHARMACEUTICAL GROUP LIMITED 500,000,000400,000,000 100,000,000 50,000,000 450,000,000350,000,000 100,000,000 4.23 1% 0.003%0.005% 0.001 2211
105;0(5 7/(94(*,
2 3 4 5 17 22 23 24 26 27 28 1 2017 7 31 2017 7 31 2017 6 29 2017 6 29 2017 6 29 2017 6 29 2017 6 29 2017 6 29 2017 6 29 2017 6 29 2017 2 26 23 2305-06 600 S2 11 Cricket Square, Hutchins Drive PO Box 2681
16,45629, % GDP % %109.6 Euromonitor International
Frost & Sullivan Frost & SullivanFrost & Sullivan Frost & SullivanFrost & SullivanFrost & Sullivan Frost & SullivanFrost & Sullivan 11,75919,10912.9% GDP16.5%GDP 16,45629,67815.9% GDP 476.0115.8 786.2246.0
目 錄 頁 次 釋 義......................................................... 1 董 事 會 函 件..................................................... 3 言.............
此乃要件 請即處理 閣下如對本通函任何方面或應採取的行動有任何疑問 應諮詢 閣下的股票經紀 其他持牌證 券商 銀行經理 律師 專業會計師或其他專業顧問 閣下如已售出或轉讓名下所有金嗓子控股集團有限公司的股份 應立即將本通函連同隨附的代 表委任表格送交買主或承讓人 或經手買賣的銀行 股票經紀或其他代理人 以便轉交買主或 承讓人 香 交易及結算所有限公司及香 聯合交易所有限公司對本通函的內容概不負責 對其準確性
i
中國新高教集團有限公司 China New Higher Education Group Limited ( 在開曼群島註冊成立之有限公司 ) 股份代號 :2001 2016 年報 .... 1.... 5... 6... 18.... 29... 78... 89.... 95... 96... 97... 99... 100... 102.... 152... 154 i 1 1 20 2001
Winning Tower Group Holdings Limited 350,000, ,000,000 70,000, ,000, ,000,000 70,000,000 35,000, % % 0.005% 0.01
Winning Tower Group Holdings Limited 8362 Winning Tower Group Holdings Limited 350,000,000 280,000,000 70,000,000 315,000,000 245,000,000 70,000,000 35,000,000 0.22 0.18 1% 0.0027% 0.005% 0.01 8362 32
China Xinhua Education Group Limited 中國新華教育集團有限公司 (Incorporated in the Cayman Islands with limited liability) ( 於開曼群島註冊成立之有限公司 ) Stock Code 股份代號 : 02779 Annual Report 2017 年報 2017 1 2 3 4 6 19 27 65 75
HIB 73%II 27% (37.1%) II A+C 57.1%34.9% 28.0%47.6%
1 2 1 18.0%23.4%6.9% 10.7% 1 8.7% 1 II 64% II54% 79%72% 3 2 26,5003,500 90070% 4 1,250 10150020% 4 1 Frost & Sullivan II II II II 2 Frost & Sullivan 3 Frost & Sullivan 4 1915 6 HIB 73%II 27% (37.1%) II
XINYI SOLAR HOLDINGS LIMITED V
Xinyi Solar Holdings Limited 信義光能控股有限公司 ( 根據開曼群島法例註冊成立的有限公司 ) 股份代號 :968 以介紹形式在香港聯合交易所有限公司主板上市 保薦人 XINYI SOLAR HOLDINGS LIMITED 968 571V (1) (1)............ (2)... (2)... (3)... (1) (2) (3) 100 100 ...
4. 27(2) 5. 6. 7. 8. 0.01 10,000,000,000 0.01 9.
1. 2. Codan Trust Company (Cayman) Limited Cricket Square, Hutchins Drive, PO Box 2681, Grand Cayman, KY1-1111, Cayman Islands 3. (a) (b) 4. 27(2) 5. 6. 7. 8. 0.01 10,000,000,000 0.01 9. A 1 2 3 4-7 8-9
4 37,919 40,859 6 (1,752) (10,323) 36,167 30,536 35,919 30, (430) 36,167 30,
RIVERINE CHINA HOLDINGS LIMITED 1417 2017 12 31 2017 12 31 2016 12 31 2017 12 31 3(a) 363,303 309,268 4(a) (296,434) (248,625) 66,869 60,643 3(b) 7,611 10,283 (4,682) (4,188) (42,690) (31,267) 5 (1,496)
PHOENIX MEDIA INVESTMENT (HOLDINGS) LIMITED ,836,813, % 113,195, ,660,000 74,220,000 1
PHOENIX MEDIA INVESTMENT (HOLDINGS) LIMITED 02008 2018 6 30 2018 6 30 1,836,813,000 15.2% 113,195,000 14.1 8,660,000 74,220,000 1 1,836,813,000 2017 6 30 1,594,557,000 15.2% 13.0% 1,950,008,000 2017 6
2898 2016 2 3 4 8 11 21 30 32 33 34 36 37 39 94 1 2016 122 FCCA, CPA Cricket Square, Hutchins Drive, P.O. Box 2681, Grand Cayman KY1-1111, Cayman Islands. 9 3007A-B 11 5 Conyers Dill & Pearman Cricket
ASCENT INTERNATIONAL HOLDINGS LIMITED 264 8510 15 18 48 ................................................................ 1........................................................... 3............................................
4. 27(2) 5. 6. 7. 8. 10,000,000 1,000,000,000 0.01 9. 2
Keen Ocean International Holding Limited 1. Keen Ocean International Holding Limited 2. Codan Trust Company (Cayman) Limited Cricket Square, Hutchins Drive, PO Box 2681, Grand Cayman, KY1-1111, Cayman
2 4 5 8 13 16 26 32 33 34 35 37 38 40 84
2014 2 4 5 8 13 16 26 32 33 34 35 37 38 40 84 03303 2006 9 21 800,154,278 http://www.jutal.com Cricket Square, Hutchins Drive, P.O. Box 2681, Grand Cayman, KY1-1111, Cayman Islands 9 11 1102 1103 518068
( 於開曼群島註冊成立之有限公司 ) 股份代號 : 1868.HK; 911868.TDR 2 4 11 23 25 27 29 31 32 46 2017 2 2017 183 22 10 8 1 20 2001 Cricket Square Hutchins Drive P.O. Box 2681 Grand Cayman KY1-1111 Cayman Islands 138 15 Royal
37.8% # 1918 #
波司登國際控股有限公司 ( 於開曼群島註冊成立之有限責任公司 ) 股份代號 : 3998 2013/14 年報 37.8% # 1918 # 2 4 7 10 36 45 49 61 63 65 67 69 70 72 146 148 2 2013/14 282.29 75.73R&F 201312 45 2013 2013/14 3 4 2013/14 ( ) 8,237,894 9,324,539
於開曼群島註冊成立之有限公司 股份代號 2211 Annual Report 2013 年 度 報 告 JINTIAN PHARMACEUTICAL GROUP LIMITED 金天醫藥集團股份有限公司 JINTIAN PHARMACEUTICAL GROUP LIMITED 金 天 醫 藥 集 團 股 份 有 限 公 司 2013 年度報告 Annual Report 2013 JINTIAN PHARMACEUTICAL
LILANZ L2 31
CHINA LILANG LIMITED CHINA LILANG LIMITED CHINA LILANG LIMITED 中國利郎有限公司 於開曼群島註冊成立之有限公司 股份代號 1234 中國利郎有限公司 (Incorporated in the Cayman Islands with limited liability) (Stock Code: 1234) 中國利郎有限公司 ANNUAL
目 錄 公 司 資 料 釋 義 財 務 概 要 集 團 架 構 行 政 總 裁 報 告 管 理 層 討 論 及 分 析 董 事 及 高 級 管 理 層 簡 介 企 業 管 治 報 告 董 事 會 報 告 獨 立 核 數 師 報 告 經 審 核 財 務 報 表 2 3 5 7 9 13 23 29 4
China Dredging Environment Protection Holdings Limited : 871 871 2014 目 錄 公 司 資 料 釋 義 財 務 概 要 集 團 架 構 行 政 總 裁 報 告 管 理 層 討 論 及 分 析 董 事 及 高 級 管 理 層 簡 介 企 業 管 治 報 告 董 事 會 報 告 獨 立 核 數 師 報 告 經 審 核 財 務 報 表 2
01565 32,706 14,252 2,002 73.6% 69.5% 77.4% 15 2
2 3-4 5-6 7-9 10-15 16-19 20-60 61-70 71-72 73 74 75-76 77 78-79 80-140 141-146 01565 32,706 14,252 2,002 73.6% 69.5% 77.4% 15 2 15 43 77 3 34 Conyers Dill & Pearman Cricket Square Hutchins Drive P.O.
巨騰國際控股有限公司
Ju Teng International Holdings Limited 巨騰國際控股有限公司 ( 於開曼群島註冊成立之有限公司 ) ( 股份代號 : 3336) 2 3 4 6 8 10 19 25 27 28 29 30 32 33 86 CA, CPA CA, CPA Cricket Square Hutchins Drive P.O. Box 2681 Grand Cayman KY1-1111
22 Cricket Square Hutchins Drive P.O. Box 2681 Grand Cayman KY1-1111 Cayman Islands 1 15 02 2016 2 Codan Trust Company (Cayman) Limited Cricket Square Hutchins Drive P.O. Box 2681 Grand Cayman KY1-1111
Kong Shum Union Property Management (Holding) Limited 100,000,000 0.5 1% 0.003% 0.005% 0.3 0.01 8181 32 342C 2013 10 7 0.5 0.3 2013 10 7 www.hkgem.com
8181 Kong Shum Union Property Management (Holding) Limited 100,000,000 0.5 1% 0.003% 0.005% 0.3 0.01 8181 32 342C 2013 10 7 0.5 0.3 2013 10 7 www.hkgem.com www.kongshum.com.hk 2013 9 30 www.hkgem.com i
HUAXI HOLDINGS COMPANY LIMITED : 75,000,000 60,000,000 15,000,000 : 67,500,000 : 7,500,000 : %0.003% 0.005% : 0.01 : C
HUAXI HOLDINGS COMPANY LIMITED 華禧控股有限公司 HUAXI HOLDINGS COMPANY LIMITED 華禧控股有限公司 於開曼群島註冊成立的有限公司 股份代號 1689 股份發售 HUAXI HOLDINGS COMPANY LIMITED 華禧控股有限公司 保薦人 獨家賬簿管理人及獨家牽頭經辦人 海通國際資本有限公司 海通國際證券有限公司 HUAXI HOLDINGS
i
COUNTRY GARDEN HOLDINGS COMPANY LIMITED 2007 2015 5 20 10 88 JW 3(1-4) 19 23 48 183 22 2015 4 14 ... 1 1.... 4 2.... 4 3.... 4 4.... 5 5.... 5 6.... 5 7.... 6 8.... 6 9.... 6... 7... 11... 19 i 2015 5
商務園區運營專家 www.yidachina.com 2016 ANNUAL REPORT 年度報告 億 達 中國控股有限公 中國控股有限公司 司 中華人民共和國 中國 總部 Headquarter In The People s Republic Of China ( PRC ) 中國遼寧省大連市沙河口區東北路93號億達廣場4座 Block 4, Yida Plaza, 93 Northeast
2 5 14 15 16 18 20 22 51 1 2018 MH, FCCA, FCPA (PRACTISING), ACA, CTA (HK), FHKIoD UFJ Conyers Dill & Pearman, Cayman 2018 2 18 29 A Century Yard Cricket Square Hutchins Drive P.O. Box 2681GT George Town
,801,000 1,473,691 20,764 12,778 (548,084) (452,982) (483,269) (395,241) (97,289) (66,548) (278,473) (209,777) (85,45
Tsui Wah Holdings Limited 1314 2015 3 31 3 31 2015 2014 1,801,000 1,473,691 22.2% # 1,266,388 1,105,011 14.6% 522,188 355,412 46.9% ## 12,424 13,268 (6.4%) 157,591 156,043 1.0% 157,407 156,031 0.9% 184
Annual Report 年報 2015 2015 Annual Report 年報 2015 02 03 04 06 18 29 44 48 50 51 52 53 54 56 110 02 Royal Bank of Canada Trust Company (Cayman) Limited 4th Floor, Royal Bank House 24 Shedden Road, George
China Dredging Environment Protection Holdings Limited 871 2015 2 3 5 6 13 20 22 23 25 26 27 Cricket Square, Hutchins Drive, P.O. Box 2681, Grand Cayman KY1-1111, Cayman Islands 1 168 200 36 19 Codan Trust
untitled
2015 SINO BIOPHARMACEUTICAL LIMITED : 1177 2 5 9 10 13 19 31 47 53 55 57 58 59 61 63 65 1 + 130 2 GMP PVC GMP GMP GMP CN20110001 MSCI http://www.sinobiopharm.com GMP GMP 3 4 1.1 55.588% 75% 55 60% 55.6%
CHINA CORN OIL Company Limited 1006 09 2 3 4 11 16 26 33 35 36 37 38 39 40 82 Butterfield Fulcrum Group (Cayman) Limited Butterfield House 68 Fort Street P.O. Box 609 Grand Cayman KY1-1107 Cayman Islands
,881,477 2,114,317 8 (2,384,197) (1,630,089) 497, ,228 4,966 6, ,106 20,908 8 (28,402) (24
1982 2018 9 30 9 30 2018 2017 2,881.5 2,114.3 +36.3% 497.3 484.2 +2.7% 17.3% 22.9% -5.6 236.0 292.1-19.2% 241.2 292.1-17.4% 8.4% 13.8% -5.4 10.4 14.1-26.2% 10.4 14.1-26.2% 3.6 5.0 1 2018 9 30 2017 9 30
B & S INTERNATIONAL HOLDINGS LTD. 100,000,000 10,000,000 90,000, % % 0.005% C
B & S International Holdings Ltd. 1705 B & S INTERNATIONAL HOLDINGS LTD. 100,000,000 10,000,000 90,000,000 1.001.0% 0.0027% 0.005% 0.01 1705 32 342C 1.000.80 www.hkexnews.hkwww.bandshk.com (1) www.hkexnews.hk
China SCE_12IR_Cover_ol.pdf 1 12年8月23日 下午5:54 C M Y CM MY CY CMY K 1. 2 2. 4 3. 5 4. 15 5. 17 6. 19 7. 21 8. 23 9. 25 10. 26 1 2012 5 10 2012 4 1 2012 4 1 2012 4 1 2012 4 1 2012 4 1 2012 4 1 2012 4 1 Cricket
untitled
KML Technology Group Limited (a) (b) (c) (d) (e) (f) (g) (h) (i) (j) (k) 32 [ ] KML Technology Group Limited [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ][] [ ] [ ] 1%0.0027% 0.005% [ ] 0.01 [ ] [ ] [ ]
C Ann.indd
20171231 20171231138.792016 46.2% 23.6%0.5 8.112016 101.3% 6.5%20164.3% 33.192016101.2% 12.299.93 * 1 20171231 20171231 2017 2016 3 13,879,207 9,495,022 (10,598,430) (7,202,155) 3,280,777 2,292,867 4 106,810
7 1,142, ,713 9 (920,417) (795,244) 221, , ,013 2, ,593 42,664 9 (52,237) (39,466) 9 (77,748) (77,768) 112,236 76,
TEN PAO GROUP HOLDINGS LIMITED 1979 21.0% 1,142.0 39.5% 300.4 75.8 26.5% 70.4 86.8% 221.6 49.3% 3.719.4% 45.6% 109.3 8 2 1 7 1,142,032 943,713 9 (920,417) (795,244) 221,615 148,469 8 9,013 2,737 8 11,593
* 3,000,000, ,000,000 2,700,000, %0.004% 0.005% C %0.004%0.005% (i)144a (ii) 501(a) (iii)s *
* 3,000,000,000 300,000,000 2,700,000,000 1.71 1%0.004% 0.005% 0.01 1387 32 342C 1.711.40 1.711%0.004%0.005% (i)144a (ii) 501(a) (iii)s903904 * (1) (2)................. (3)................ eipowww.eipo.com.hk
untitled
2 3 6 13 17 25 31 44 48 49 51 52 54 116 1 Cricket Square, Hutchins Drive P.O. Box 2681 Grand Cayman KY1-1111 Cayman Islands B 9-A 1 36 SMP Partners (Cayman) Limited 3rd Floor, Royal Bank House 24 Shedden
(於開曼群島註冊成立之有限公司) (股份代號: 587) 中期 報 告 20 14 /15 Hua Han Bio-Pharmaceutical Holdings Limited Hua Han Bio-Pharmaceutical Holdings Limited 華瀚生物製藥控股有限公司 Hua Han Bio-Pharmaceutical Holdings Limited 華瀚生物製藥控股有限公司
( 於開曼群島註冊成立之股份有限公司 ) 股份代號 :1980 年度報告 2015 2 3 5 6 8 22 23 28 70 81 83 90 20082014 7 9 2015 2 Floor 4, Willow House Cricket Square P.O. Box 2804 Grand Cayman KY1-1112 Cayman Islands 186 3A09 1 36 Offshore
Qinqin Foodstuffs Group (Cayman) Company Limited V E.
親親食品集團 ( 開曼 ) 股份有限公司 Qinqin Foodstuffs Group (Cayman) Company Limited ( 於開曼群島註冊成立的有限公司 ) 股份代號 : 1583 以介紹方式在香港聯合交易所有限公司主板上市 獨家保薦人 Qinqin Foodstuffs Group (Cayman) Company Limited 1583 571V E. (1).........
China International Capital Corporation Limited XIVA A ,832,853,595 2,720,718,
China International Capital Corporation Limited 3908 13.09 571 XIVA A 2018 9 30 2018 9 30 2018 1 1 2018 9 30 9,832,853,595 2,720,718,630 2017 4 1 2018 1 1 2018 9 302017 1 1 2017 9 30 2017 4 1 2017 9 30
2016 年報 REPORT Annual Report 2016 年報 (於開曼群島註冊成立之有限公司) 股份代號 : 238 2016 ANNUAL (Incorporated in the Cayman Islands with limited liabilty) Stock Code: 238 2 8 9 12 25 32 42 53 57 63 64 65 66 67 69 124 PO
KO R AD I O R elsewhere 生活在別處 KORADIOR HOLDINGS LIMITED 珂萊蒂爾控股有限公司 於開曼群島註冊成立之有限公司 股份代號 3709 二零一 四 年 年報 2 3 4-5 6 7-8 9-19 20-23 24-30 31-45 46-47 48 49 50 51 52 53-98 1 Koradior La Koradior Koradior elsewhere
REDCO PROPERTIES GROUP LIMITED % 1, % 1, % , %
REDCO PROPERTIES GROUP LIMITED 1622 28.4% 1,646.8 48.2% 1,694.9 113.3% 289.1 1,256.4 44% 3.8 18.07 1 4 1,646,835 1,282,569 (1,026,015) (944,546) 620,820 338,023 2,069 278 (45,785) (26,606) (85,022) (75,145)